Minghua H. Yang

No. 138 Tongzipo Road
Changsha, 410013, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications

Retraction notice to "Extracellular HMGB1 prevents necroptosis in acute myeloid leukemia cells" [Biomedicine & Pharmacotherapy 112 (2019) 108714].

Retraction notice to "Extracellular HMGB1 prevents necroptosis in acute myeloid leukemia cells" [Biomedicine & Pharmacotherapy 112 (2019) 108714].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 17, 2026

Pharmacovigilance assessment of vinorelbine-associated adverse events using FAERS and VigiBase.

Pharmacovigilance assessment of vinorelbine-associated adverse events using FAERS and VigiBase.

Journal: Medicine
Published: December 24, 2025

Efficacy of chimeric antigen receptor T-cell therapy in testicular relapse of pediatric acute lymphoblastic leukemia: a multicenter retrospective study.

Efficacy of chimeric antigen receptor T-cell therapy in testicular relapse of pediatric acute lymphoblastic leukemia: a multicenter retrospective study.

Journal: Frontiers in immunology
Published: December 12, 2025

A low- versus standard-dose regimen as induction for pediatric AML: a multicenter, randomized noninferiority trial.

A low- versus standard-dose regimen as induction for pediatric AML: a multicenter, randomized noninferiority trial.

Journal: Blood
Published: July 23, 2025

Low- vs standard-dose regimens as induction for pediatric AML: a multicenter, randomized noninferiority trial.

Low- vs standard-dose regimens as induction for pediatric AML: a multicenter, randomized noninferiority trial.

Journal: Blood
Published: July 23, 2025

Author Correction: PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation.

Author Correction: PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation.

Journal: Nature communications
Published: July 04, 2025

Therapeutic targeting of cell death-immune crosstalk in cancer to rewire the tumor immune microenvironment.

Therapeutic targeting of cell death-immune crosstalk in cancer to rewire the tumor immune microenvironment.

Journal: Molecular cancer
Published: June 06, 2025

Lipid biomarkers of GVHD in allogeneic stem hematopoietic cell transplantation patients.

Lipid biomarkers of GVHD in allogeneic stem hematopoietic cell transplantation patients.

Journal: Frontiers in immunology
Published: May 09, 2025

Attention to the interactions between vincristine and triazole antifungals: perspectives from real-world retrospective analysis and pharmacovigilance assessment.

Attention to the interactions between vincristine and triazole antifungals: perspectives from real-world retrospective analysis and pharmacovigilance assessment.

Journal: Expert opinion on drug safety
Published: April 18, 2025

Metabolic reprogramming promotes apoptosis resistance in acute lymphoblastic leukemia through CASP3 lactylation.

Metabolic reprogramming promotes apoptosis resistance in acute lymphoblastic leukemia through CASP3 lactylation.

Journal: Molecular cancer
Published: March 02, 2025

Statin‑associated myasthenia gravis: a real-world retrospective and pharmacovigilance study.

Statin‑associated myasthenia gravis: a real-world retrospective and pharmacovigilance study.

Journal: Expert opinion on drug safety
Published: February 12, 2025

Arsenic trioxide-based nanoparticles for enhanced chemotherapy by activating pyroptosis.

Arsenic trioxide-based nanoparticles for enhanced chemotherapy by activating pyroptosis.

Journal: Acta pharmaceutica Sinica. B
Published: January 11, 2025
Showing 1-12 of 87

Last Updated: 09/26/2026